Effectiveness and Tolerance of Cicaplast Baume B5 on Re-epithelialization After Superficial CO2 Laser Resurfacing
This study aims to evaluate the effectiveness and tolerance of Cicaplast Baume B5 on the healing process after superficial CO2 laser resurfacing, by assessing the number of days required for complete re-epithelialization.
superficial CO2 laser resurfacing
+ Laser untreated side
Other Study
Summary
Study start date: January 16, 2023
Actual date on which the first participant was enrolled.This study aims to test how well a skin balm called Cicaplast Baume B5 helps heal the skin after a cosmetic procedure known as superficial CO2 laser resurfacing. This procedure is often used to improve skin appearance by removing the outer layer of skin. The study focuses on how quickly the skin heals when using this balm compared to areas that do not receive the treatment. It involves 25 participants who have undergone this laser treatment. The goal is to see if Cicaplast Baume B5 can speed up skin recovery, which can benefit people seeking faster healing after cosmetic skin treatments. Participants in this study apply Cicaplast Baume B5 to the treated skin areas after their laser procedure. Researchers then closely monitor the healing process, specifically looking at how many days it takes for the skin to completely re-epithelialize, which means for new skin to form over the treated area. The study uses specific statistical methods to measure the effectiveness of the balm, ensuring results are accurate and reliable. The outcomes are compared between areas of skin treated with the balm and those without, to determine any differences in healing time. The study is conducted following strict ethical and regulatory guidelines, ensuring the safety and well-being of all participants.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.25 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * phototype II and III on the Fitzpatrick scale * subjects with normal clinical examination and medical history compatible with the study Exclusion Criteria: * subject with underlying pathology that may interfere with the interpretation of the study results (dermatological history of psoriasis, eczema, urticaria... or suspicion/history of allergies to cosmetics), skin abnormality (scars, excessive hair growth, tattoos...) in the test areas (back, midline), systemic pathology * subject with excessive exposure to natural (sun) or artificial (tanning salon) ultraviolet light (UV) 4 weeks prior to the initial visit or who anticipates such exposure during the study * subject who has taken systemic treatment for more than 5 days in the month prior to inclusion
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location